SOD1 and amyotrophic lateral sclerosis: In familial ALS, where SOD1 mutations lead to excessive ROS, pre-clinical CRISPR-mediated correction of the gene leads to reduced oxidative stress with delayed neurodegeneration and lengthened life expectancy.